Literature DB >> 34505197

Fibroepithelial tumours of the breast-a review.

Melinda F Lerwill1, Andrew H S Lee2, Puay Hoon Tan3.   

Abstract

Fibroepithelial tumours of the breast are biphasic neoplasms composed of both epithelial and stromal elements, including the common fibroadenoma and the infrequent phyllodes tumour. The admixture of epithelium and stroma in the fibroadenoma shows intra- and pericanalicular patterns, and may display a variety of histological changes. Fibroadenoma variants include the cellular, juvenile, myxoid and complex forms. The cellular fibroadenoma may be difficult to distinguish from the benign phyllodes tumour. Stromal mitotic activity can be increased in fibroadenomas in the young and pregnant patients. Phyllodes tumours, neoplasms with the potential for recurrence, show an exaggerated intracanalicular growth pattern with broad stromal fronded architecture and stromal hypercellularity. They are graded into benign, borderline and malignant forms based on histological assessment of stromal features of hypercellularity, atypia, mitotic activity, overgrowth and the nature of the tumour borders. Classification of phyllodes tumours is imperfect, compounded by tumour heterogeneity with overlapping microscopic features among the different grades, especially in the borderline category. Malignant phyllodes tumours can metastasise and cause death. Determining which phyllodes tumours may behave aggressively has been difficult. The discovery of MED12 mutations in the pathogenesis of fibroepithelial tumours, together with other gene abnormalities in the progression pathway, has allowed refinements in diagnosis and prognosis.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Core biopsy; Differential diagnosis; Fibroepithelial; Prognosis

Mesh:

Year:  2021        PMID: 34505197     DOI: 10.1007/s00428-021-03175-6

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  55 in total

1.  Recurrent phyllodes tumor in the male breast in a background of gynaecomastia.

Authors:  Abhijit Chougule; Amanjit Bal; Pulkit Rastogi; Ashim Das
Journal:  Breast Dis       Date:  2015

2.  Myxoid fibroadenomas differ from conventional fibroadenomas: a hypothesis-generating study.

Authors:  John R Lozada; Kathleen A Burke; Aoife Maguire; Fresia Pareja; Raymond S Lim; Jisun Kim; Rodrigo Gularte-Merida; Melissa P Murray; Edi Brogi; Britta Weigelt; Jorge S Reis-Filho; Felipe C Geyer
Journal:  Histopathology       Date:  2017-07-05       Impact factor: 5.087

3.  Myxoid fibroadenoma and allied conditions (myxomatosis) of the breast. A heritable disorder with special associations including cardiac and cutaneous myxomas.

Authors:  J A Carney; B C Toorkey
Journal:  Am J Surg Pathol       Date:  1991-08       Impact factor: 6.394

4.  A subset of malignant phyllodes tumors express p63 and p40: a diagnostic pitfall in breast core needle biopsies.

Authors:  Ashley Cimino-Mathews; Rajni Sharma; Peter B Illei; Russell Vang; Pedram Argani
Journal:  Am J Surg Pathol       Date:  2014-12       Impact factor: 6.394

5.  Benign phyllodes tumor of the breast recurring as a malignant phyllodes tumor and spindle cell metaplastic carcinoma.

Authors:  Kristen E Muller; Laura J Tafe; Francine B de Abreu; Jason D Peterson; Wendy A Wells; Richard J Barth; Jonathan D Marotti
Journal:  Hum Pathol       Date:  2014-11-04       Impact factor: 3.466

6.  Bilateral presentation of fibroadenoma with digital fibroma-like inclusions in the male breast.

Authors:  Sandra J Shin; Paul Peter Rosen
Journal:  Arch Pathol Lab Med       Date:  2007-07       Impact factor: 5.534

7.  Complex fibroadenoma and breast cancer risk: a Mayo Clinic Benign Breast Disease Cohort Study.

Authors:  Aziza Nassar; Daniel W Visscher; Amy C Degnim; Ryan D Frank; Robert A Vierkant; Marlene Frost; Derek C Radisky; Celine M Vachon; Ruth A Kraft; Lynn C Hartmann; Karthik Ghosh
Journal:  Breast Cancer Res Treat       Date:  2015-08-12       Impact factor: 4.872

8.  Juvenile (cellular) adenofibromas. A clinicopathologic study.

Authors:  A M Pike; H A Oberman
Journal:  Am J Surg Pathol       Date:  1985-10       Impact factor: 6.394

9.  Lipophyllodes of the breast. A reappraisal of fat-rich tumors of the breast based on 22 cases integrated by immunohistochemical study, molecular pathology insights, and clinical follow-up.

Authors:  Carlos E Bacchi; Sheila C Wludarski; Janez Lamovec; David Ben Dor; Elisa Ober; Tiziana Salviato; Fabrizio Zanconati; Giovanna De Maglio; Stefano Pizzolitto; Stefano Sioletic; Giovanni Falconieri
Journal:  Ann Diagn Pathol       Date:  2015-12-10       Impact factor: 2.090

10.  Focal Anomalous Expression of Cytokeratin and p63 in Malignant Phyllodes Tumor: A Comparison With Spindle Cell Metaplastic Carcinoma.

Authors:  Meenakshi Bansal; Jianzhi Chen; Xi Wang
Journal:  Appl Immunohistochem Mol Morphol       Date:  2018-03
View more
  2 in total

1.  Genomic characteristics of two breast malignant phyllodes tumors during pregnancy and lactation identified through whole-exome sequencing.

Authors:  Tinge Lei; Mengjia Shen; Xu Deng; Yongqiang Shi; Yan Peng; Hui Wang; Tongbing Chen
Journal:  Orphanet J Rare Dis       Date:  2022-10-21       Impact factor: 4.303

Review 2.  An Update on the General Features of Breast Cancer in Male Patients-A Literature Review.

Authors:  Sinziana Ionescu; Alin Codrut Nicolescu; Marian Marincas; Octavia-Luciana Madge; Laurentiu Simion
Journal:  Diagnostics (Basel)       Date:  2022-06-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.